COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 595: Articles 5941-5950  | Next

Prevalence and risk factors for long COVID after mild disease: a longitudinal study with a symptomatic control group.
Caze Ceron, A. B., Silva, T. C., Bomfim, A. P., de Souza, G. L., Azevedo, A. C. A., Brasil, M. Q. A., Santos, N. R., Khouri, R., Dan, J., Bandeira, A. C., Cavalcanti, L. P. d. G., Netto, M. B., Barral, A. M. P., Barbosa, C. G., Boaventura, V. S.
10.1101/2022.09.15.22279958 — Posted: 2022-09-17
Neutralizing antibodies following three doses of BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron predominant wave
Yamamoto, S., Matsuda, K., Maeda, K., Horii, K., Okudera, K., Oshiro, Y., Inamura, N., TAKEUCHI, J. S., Konishi, M., Ozeki, M., Mizoue, T., Sugiyama, H., Aoyanagi, N., Mitsuya, H., Sugiura, W., Ohmagari, N.
10.1101/2022.09.15.22280009 — Posted: 2022-09-17
Hospital contact patterns and vulnerability to SARS-CoV-2 outbreaks
Shirreff, G., Huynh, B.-T., Duval, A., Pereira, L. C., Annane, D., Dinh, A., Lambotte, O., Bulifon, S., Guichardon, M., Beaune, S., Toubiana, J., Kermovant-Duchemin, E., Cheron, G., Cordel, H., Argaud, L., Douplat, M., Abraham, P., Tazarourte, K., Martin-Gaujard, G., Vanhems, P., Hilliquin, D., Nguyen, D., Chelius, G., Fraboulet, A., Temime, L., Opatowski, L., Guillemot, D.
10.1101/2022.09.13.22279837 — Posted: 2022-09-17
Differential contagiousness of respiratory disease across the United States
Mallela, A., Lin, Y. T., Hlavacek, W. S.
10.1101/2022.09.15.22279948 — Posted: 2022-09-17
Low Dimensional Chaotic Attractors in SARS-CoV-2's Regional Epidemiological Data
Goncalves, C. P. d. S.
10.1101/2022.09.16.22280044 — Posted: 2022-09-17
Using Generalized Structured Additive Regression Models to Determine Factors Associated with and Clusters for COVID-19 Hospital Deaths in South Africa
Maposa, I., Welch, R., Ozougwu, L., Arendse, T., Mudara, C., Blumberg, L., Jassat, W.
10.1101/2022.09.16.22280020 — Posted: 2022-09-17
Mathematical modeling identifies optimal dosing schedules for COVID-19 vaccines to minimize breakthrough infections
Dogra, P., Schiavone, C., Wang, Z., Ramirez, J. R., Caserta, S., Staquicini, D. I., Markosian, C., Wang, J., Sostman, H. D., Pasqualini, R., Arap, W., Cristini, V.
10.1101/2022.09.14.22279959 — Posted: 2022-09-17
Bayesian Prediction of Severe Outcomes in the LabMarCS: Laboratory Markers of COVID-19 Severity - Bristol Cohort
Sullivan, B., Barker, E., Williams, P., MacGregor, L., Bhamber, R., Thomas, M., Gurney, S., Hyams, C., Whiteway, A., Cooper, J. A., McWilliams, C., Turner, K., Dowsey, A. W., Albur, M.
10.1101/2022.09.16.22279985 — Posted: 2022-09-17
Post-vaccination neutralization responses to Omicron sub-variants
Jacobsen, H., Katzmarzyk, M., Higdon, M. M., Cobos Jimenez, V., Sitaras, I., Bar-Zeev, N., Deloria Knoll, M.
10.1101/2022.09.16.22280017 — Posted: 2022-09-17
Semantic and population analysis of the genetic targets related to COVID-19 and its association with genes and diseases
Papageorgiou, L., Papakonstantinou, E., Diakou, I., Pierouli, K., Dragoumani, K., Bacopoulou, F., Chrousos, G. P., Eliopoulos, E., Vlachakis, D.
10.1101/2022.09.16.508278 — Posted: 2022-09-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).